Bioequivalence Studies | Lambda

Backed by excellent scientific expertise with capabilities of handling challenging studies, Lambda's Bioavailability/Bioequivalence Studies offer global access to 800+ clinical beds inclusive of 85+ specialized beds designed for specific studies. Robust recruitment & housing options enable us to provide customized sponsor/study requirements. Till date, over 50 successful inspections by leading regulatory agencies across all Lambda facilities have been completed.